Publications by authors named "Kristin M Follmer"
Article Synopsis
- The study focused on enhancing patient enrollment in the CISTO bladder cancer trial by identifying effective operational tools and strategies.
- The main strategy, CISTOquestion, an email system for addressing patient eligibility inquiries, significantly increased average patient screenings and enrollments at study sites after its implementation.
- Survey responses indicated that CISTOquestion was perceived as a valuable resource, particularly in sites with higher exclusion rates, highlighting its role in improving trial participation.
Background: Bladder cancer poses a significant public health burden, with high recurrence and progression rates in patients with non-muscle-invasive bladder cancer (NMIBC). Current treatment options include bladder-sparing therapies (BST) and radical cystectomy, both with associated risks and benefits. However, evidence supporting optimal management decisions for patients with recurrent high-grade NMIBC remains limited, leading to uncertainty for patients and clinicians.
View Article and Find Full Text PDFBackground: Patient-centered approaches to research design are particularly important for diseases with complex treatment decision-making, such as recurrent, high-grade non-muscle-invasive bladder cancer (NMIBC). The objective of this article is to describe patient and public involvement (PPI) in designing a large, pragmatic observational trial and to articulate barriers, challenges, and lessons learned for future design.
Methods: Through multistakeholder involvement, a large, pragmatic observational trial was designed to investigate the outcomes of high-risk, recurrent NMIBC, and it was titled Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer (CISTO).